Insider · CIK 0001494695
Manning Paul B
director
Files at CADL (Candel Therapeutics, Inc.). First filing Dec 18, 2024, latest Dec 18, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$7.5M bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 50Moderate | buy | CADL Candel Therapeutics, Inc. | $7.5M | 1,250,000 | +195% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | CADL Candel Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Paul B. Manning Revocable Trust | +500,000 | $6.00 | $3.0M | 1,142,406 | Dec 18, 2024 |
| Dec 16, 2024 | CADL Candel Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By BKB Growth Investments, LLC | +750,000 | $6.00 | $4.5M | 1,303,752 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.